Brellium has raised $23 million to develop its artificial intelligence-based platform that ensures regulatory compliance in clinical practice and revenue integrity. The funding round was led by Left Lane Capital and First Round Capital, with participation from Digital Health Venture Partners.
The New York-based company helps healthcare providers identify documentation errors before billing. The platform aims to reduce non-compliance risks and prevent costly insurance claim denials. Brellium serves over 215,000 providers across all 50 US states, including more than 200 provider groups in various healthcare fields.
To date, Brellium has reviewed 22 million patient visits and claims to have protected nearly $2 billion in provider revenue from write-offs. Providers are currently under intense scrutiny from both governmental and private payers, who must prove that their clinical records support billing claims and adhere to all regulations.
If notes are incomplete or billing codes are unsupported, issues can arise that lead to denied claims, reimbursement payments, and further investigations after billing. The primary goal is to detect such problems early through automated chart audits so that providers can correct deficiencies before submitting bills.
Furthermore, Brellium plans to expand its partnerships with provider groups and enter additional clinical specialties. The company introduced CortexLM, its proprietary clinical record auditing system. This platform analyzes patient records to detect documentation gaps, coding errors, and potential compliance violations, checking records against the specific requirements of each provider.
CortexLM flags issues and suggests corrections before claims reach payers, aiming to reduce the number of denied claims and prevent recoupment requests. While better documentation can lead to more accurate claims, the responsibility for verifying results and meeting payer requirements remains with the providers.
Brellium states that CortexLM has helped protect nearly $2 billion in provider revenue from write-offs. The technology also supports quality assurance through more comprehensive analysis of clinical documentation. After implementing Brellium, the company Headspace expanded its clinical quality program.
The new funding allows the company to grow beyond its current client base. Brellium is preparing to enter new markets such as cardiology, pain management, and primary care. These areas are complex due to the high volume of paperwork and intricate, specialization-dependent billing rules.
More providers will gain access to automated checks, which can significantly save time and reduce errors. Brellium also intends to delve deeper into the revenue cycle, helping healthcare organizations identify where they are losing money or risking non-compliance during billing.
The CEO emphasizes that the Brellium platform has become indispensable for healthcare providers. However, the effectiveness of these tools depends on how well teams utilize them. Staff must understand why a particular entry was flagged and what steps to take next.
Clear audit guidelines are crucial, helping people distinguish between missing information and acceptable clinical judgment variations. Additionally, providers are obligated to ensure patient data security and guarantee that automated recommendations align with their practice policies. This requires all departments and specialties to follow consistent and reliable workflows. Brellium possesses the necessary resources to further develop CortexLM and attract more clients. The next phase focuses on increasing the user base and assisting providers in ensuring compliance while protecting revenue.